Increasing the size of the specific pathogen free Indian rhesus macaques colony at the Southwest National Primate Research Center for AIDS, COVID-19 and other infectious diseases research
- Funded by National Institutes of Health (NIH)
- Total publications:0 publications
Grant number: 3P51OD011133-23S1
Grant search
Key facts
Disease
COVID-19Start & end year
19992026Known Financial Commitments (USD)
$894,342Funder
National Institutes of Health (NIH)Principal Investigator
Larry S SchlesingerResearch Location
United States of AmericaLead Research Institution
Texas Biomedical Research InstituteResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Disease models
Special Interest Tags
N/A
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
Abstract. Specific pathogen free (SPF) Indian origin Macaca mulatta (rhesus macaques) are the premier model for infectious disease research including HIV/AIDS, TB, influenza, Lyme disease, and now COVID-19. There has been an acute nationwide shortage of these animals over the past couple of decades, which has been well- documented. Multiple reasons related to the COVID-19 pandemic have made this situation more difficult. Imports of these animals from Asia have stopped, and biomedical corporates have used large number of these animals in the past year. A number of animals have also been used in COVID-19 research by investigators at virtually each of the seven National Primate Research Centers (NPRCs). Hence, there is an acute, urgent need to increase the availability of SPF Indian origin rhesus macaques. This application proposes to increase the production of these animals at the Southwest National Primate Research Center (SNPRC).